Home › Epilepsy › Ohio › Columbus
Epilepsy clinical trials in Columbus, OH
5 studies for Epilepsy are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
RecruitingPhase 1/2
- Ohio State University, Columbus
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
RecruitingPhase 2/3
- OSU, Columbus
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
RecruitingPhase 3
- The Ohio State University, Columbus
- OhioHealth Riverside Methodist Hospital, Columbus
Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
RecruitingObservational study
- Nationwide Children's, Columbus
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
RecruitingPhase 3
- OhioHealth, Columbus
About Epilepsy
Epilepsy is a brain disorder that causes people to have seizures. The seizures may be mild or severe. Learn about causes, diagnosis, and treatment.
More about Epilepsy on MedlinePlus
Epilepsy trials in other cities
- Boston, MA20 studies
- Houston, TX16 studies
- New York City, NY14 studies
- Washington, DC13 studies
- Philadelphia, PA12 studies
- Phoenix, AZ10 studies
- Cleveland, OH9 studies
- Mountain View, CA8 studies
- St. Louis, MO8 studies
- Miami, FL8 studies
- Durham, NC8 studies
- Rochester, MN8 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer54 studies
- Cancer (all types)39 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Chronic Lymphocytic Leukemia29 studies
- Metastatic Cancer26 studies
- Endometrial Cancer26 studies
- Prostate Cancer24 studies
- Multiple Myeloma24 studies
- Colorectal Cancer23 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.